Cargando…
Persistent dyslipidemia in treatment of lysosomal acid lipase deficiency
BACKGROUND: Lysosomal acid lipase deficiency (LALD) is an autosomal recessive inborn error of lipid metabolism characterized by impaired lysosomal hydrolysis and consequent accumulation of cholesteryl esters and triglycerides. The phenotypic spectrum is diverse, ranging from severe, neonatal onset f...
Autores principales: | Pritchard, Amanda Barone, Strong, Alanna, Ficicioglu, Can |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7041253/ https://www.ncbi.nlm.nih.gov/pubmed/32093730 http://dx.doi.org/10.1186/s13023-020-1328-6 |
Ejemplares similares
-
Early diagnosis of infantile-onset lysosomal acid lipase deficiency in the advent of available enzyme replacement therapy
por: Cohen, Jennifer L., et al.
Publicado: (2019) -
Lysosomal Acid Lipase Deficiency: Therapeutic Options
por: Pastores, Gregory M, et al.
Publicado: (2020) -
Clinical Features of Lysosomal Acid Lipase Deficiency
por: Burton, Barbara K., et al.
Publicado: (2015) -
Hepatosteatosis from Lysosomal Acid Lipase Deficiency
por: Zandanell, Stephan, et al.
Publicado: (2018) -
Progressive macrophage accumulation in lysosomal acid lipase deficiency
por: Lipiński, Patryk, et al.
Publicado: (2020)